Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Evidence for Substrate-Dependent Inhibition Profiles for Human Liver Aldehyde Oxidase

John T. Barr and Jeffrey P. Jones
Drug Metabolism and Disposition January 2013, 41 (1) 24-29; DOI: https://doi.org/10.1124/dmd.112.048546
John T. Barr
Department of Chemistry, Washington State University, Pullman, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey P. Jones
Department of Chemistry, Washington State University, Pullman, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 41 no. 1 24-29
DOI 
https://doi.org/10.1124/dmd.112.048546
PubMed 
22996261

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 16, 2012
  • Accepted September 20, 2012
  • Published online December 20, 2012.

Article Versions

  • Earlier version (September 20, 2012 - 09:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. John T. Barr and
  2. Jeffrey P. Jones
  1. Department of Chemistry, Washington State University, Pullman, Washington
  1. Address correspondence to:
    Jeffrey P. Jones, Washington State University, Fulmer Synthesis Building, Room 477, Pullman, WA 99164-4630. E-mail: jpj{at}wsu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2012 to April 2022

AbstractFullPdf
Sep 2012345083
Oct 2012203055
Nov 201276036
Dec 20124592279
Jan 201375817105
Feb 20131861423
Mar 2013150626
Apr 2013140817
May 2013851331
Jun 201358214
Jul 201376722
Aug 201388537
Sep 2013591244
Oct 201367917
Nov 201342520
Dec 20136647
Jan 201462919
Feb 201448712
Mar 2014531415
Apr 2014621016
May 2014481627
Jun 201438117
Jul 2014392424
Aug 20142577
Sep 20142358
Oct 20142836
Nov 20142856
Dec 201458446
Jan 201539184
Feb 2015955
Mar 2015341411
Apr 20153248
May 2015261133
Jun 20152318
Jul 2015201216
Aug 20152779
Sep 20153568
Oct 20152859
Nov 201533916
Dec 20152588
Jan 201631910
Feb 20161884
Mar 201615615
Apr 201613157
May 20161124
Jun 201681010
Jul 201621915
Aug 2016291511
Sep 20161076
Oct 201642112
Nov 20166208
Dec 2016896
Jan 20171164
Feb 20170142
Mar 201723626
Apr 20170187
May 2017196
Jun 20170111
Jul 201711010
Aug 20171155
Sep 2017195
Oct 20170173
Nov 201721813
Dec 20173206
Jan 20184204
Feb 20184163
Mar 20183237
Apr 20182184
May 20181195
Jun 20182166
Jul 2018682
Aug 20184194
Sep 20181121
Oct 20183175
Nov 20183319
Dec 20183587
Jan 20191832
Feb 20193324
Mar 20192135
Apr 201926010
May 20191222
Jun 20191015
Jul 20192522
Aug 20191153
Sep 20191024
Oct 20193134
Nov 20192163
Dec 20191923
Jan 20202221
Feb 20201000
Mar 2020513
Apr 20201564
May 20201881
Jun 2020941
Jul 20201564
Aug 20201019
Sep 20201622
Oct 20202414
Nov 2020601
Dec 20201313
Jan 2021151310
Feb 202134115
Mar 20211963
Apr 20212031
May 2021930
Jun 202115104
Jul 20211477
Aug 2021682
Sep 20212444
Oct 20211631
Nov 20212233
Dec 20212458
Jan 20222054
Feb 20221543
Mar 20221175
Apr 20221733

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 41 (1)
Drug Metabolism and Disposition
Vol. 41, Issue 1
1 Jan 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for Substrate-Dependent Inhibition Profiles for Human Liver Aldehyde Oxidase
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Substrate-Dependent Inhibition of AO

John T. Barr and Jeffrey P. Jones
Drug Metabolism and Disposition January 1, 2013, 41 (1) 24-29; DOI: https://doi.org/10.1124/dmd.112.048546

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

Substrate-Dependent Inhibition of AO

John T. Barr and Jeffrey P. Jones
Drug Metabolism and Disposition January 1, 2013, 41 (1) 24-29; DOI: https://doi.org/10.1124/dmd.112.048546
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics